Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

PCAC Votes 7-2 to INCLUDE Drugs Produced with HME on Demonstrably Difficult to Compound List

Tuesday, November 21, 2017   (0 Comments)
Posted by: Dagmar Anderson
Share |
PCAC Meeting November 21, 2017:

IACP is in attendance at the Food & Drug Administration (FDA) Pharmacy Compounding Advisory Committee (PCAC) Meeting, November 20-21, 2017, in White Oak, Maryland, and will bring you live voting results!

PLEASE NOTE: These votes are NOT final. FDA must release final guidance for this to be FINAL. These are the Committee's votes on FDA's recommendations for the API Positive List. Please contact IACP with questions at iacpinfo@iacprx.org.

Please note that IACP and other pharmacy organizations previously let Congress know that these meetings should be webcast to the public and you can now watch the PCAC live webcast here. As IACP stated within its comments that you can read here, IACP is still very disappointed that while two PCAC members have been allowed to participate via conference call for this meeting, FDA denied all stakeholder participation via conference calls even during the public meeting sections.
 
FDA PCAC November 21, 2017 - 2nd and Final Vote of the Day

Drug Products Produced Using Hot Melt Extrusion

 

Please click here to read more. 


Association Management Software Powered by YourMembership  ::  Legal